Even the long-ignored antibacterial drug crisis has recently garnered much-needed attention. However, it is well-documented that fungal infections are proliferating around the world with an estimated 1.5 million deaths per year. While healthy humans are generally not affected by fungal infections, they are a major concern to immunocompromised individuals, such as e.g. human immunodeficiency virus (HIV) patients. Additionally, modern medical treatments such as chemotherapy, transplantations and broad spectrum antibiotic courses lead to an increased population of people susceptible to fungal infections. Of particular concern are a series of species of Candida, Aspergillus and Cryptococcus which are responsible for >90% of fungal infection deaths. Amongst these, Candida species, and Candida albicans in particular, are the most prevalent cause of healthcare-associated bloodstream infections in the US.